DFO
LLY icon

Duquesne Family Office’s Eli Lilly LLY Stock Holding History

Duquesne Family Office’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8M Buy
+12,380
New +$12.6M 0.29% 67
2025
Q3 		– Sell
-100,675
Closed -$78.5M – 90
2025
Q2 		$78.5M Buy
100,675
+5,845
+6% +$4.54M 1.93% 16
2025
Q1 		$78.3M Buy
94,830
+32,640
+52% +$27.2M 2.56% 12
2024
Q4 		$48M Buy
+62,190
New +$51.5M 1.29% 20
2024
Q2 		– Sell
-61,664
Closed -$48M – 77
2024
Q1 		$48M Sell
61,664
-340,886
-85% -$243M 1.09% 23
2023
Q4 		$235M Sell
402,550
-51,565
-11% -$30.1M 7% 5
2023
Q3 		$244M Sell
454,115
-82,330
-15% -$42.4M 8.75% 4
2023
Q2 		$252M Sell
536,445
-69,765
-12% -$29.3M 8.75% 4
2023
Q1 		$208M Sell
606,210
-131,515
-18% -$44.4M 9.02% 4
2022
Q4 		$270M Buy
737,725
+252,830
+52% +$89.6M 13.36% 2
2022
Q3 		$157M Buy
484,895
+187,745
+63% +$59.5M 8.89% 2
2022
Q2 		$96.3M Buy
+297,150
New +$89.2M 6.97% 4

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Duquesne Family Office's LLY Position: Q2 2026 in Review

Duquesne Family Office opened a new position in Eli Lilly (LLY) in Q2 2026: 12,380 shares worth $14.8M. The stake represents 0.29% of the portfolio and ranks #67 among its holdings. This is a return to the name: Duquesne Family Office previously reported a position in LLY as recently as Q2 2025.

Duquesne Family Office first reported a position in LLY in Q2 2022 and has held it in 12 quarters since. The position peaked at $270M in Q4 2022. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Duquesne Family Office held 12,380 shares of Eli Lilly worth $14.8M as of Q2 2026.
  • Eli Lilly was a new Duquesne Family Office position in Q2 2026.
  • Eli Lilly made up 0.29% of Duquesne Family Office's portfolio in Q2 2026, its #67 holding.
  • Duquesne Family Office first reported a position in Eli Lilly in Q2 2022 and has held it in 12 quarters since.
  • Duquesne Family Office's Eli Lilly position peaked at $270M in Q4 2022.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Duquesne Family Office's 13F filing for Q2 2026, filed 14 Aug 2026.